Pharmaceuticals & Life Sciences

Protect Every Dollar
From Molecule to Market.

Gross-to-net erosion, clinical trial overruns, and regulatory complexity drain billions from pharmaceutical profitability. ProfitGuard delivers AI-powered profit protection across the entire pharma value chain — GxP-compliant, FDA-validated, audit-ready.

$23M

Avg. Annual G2N Savings

99.2%

Rebate Accuracy

22%

Trial Cost Reduction

GxP

Fully Validated

Start Free Trial Request Pharma Assessment

Pharma Profit Challenges We Solve

Drug Pricing Margin Erosion

$45M+ annual margin leakage at mid-size pharma

Rebate clawbacks, 340B pricing compliance, Medicaid best price calculations, and WAC-to-net spread compression silently erode margins across the product portfolio.

Clinical Trial Cost Overruns

35% average cost overrun per trial

Phase II/III trials run 30-40% over budget on average. Investigator site payments, CRO pass-through costs, and protocol amendment expenses lack real-time visibility.

Regulatory Compliance Complexity

$8M+ annual compliance spend per product

FDA, EMA, PMDA, and 100+ national regulators each require different documentation, reporting, and audit trails — across manufacturing, distribution, and commercial operations.

Supply Chain Integrity & Serialization

$2.5B industry loss to counterfeit drugs annually

DSCSA/FMD serialization mandates, cold chain integrity, and counterfeit risk across global distribution networks create multi-dimensional profit protection challenges.

Purpose-Built for Pharma Profitability

Drug Pricing Intelligence Engine

Real-time monitoring of gross-to-net pricing across all channels — catching rebate miscalculations, 340B duplicate discounts, Medicaid best price violations, and WAC drift before they compound.

$18M average annual gross-to-net savings

Gross-to-net waterfall analysis by product and channel

Rebate accrual accuracy monitoring (government + commercial)

340B duplicate discount prevention with real-time screening

Medicaid best price calculation validation

Chargebacks and returns provision optimization

Price concession trending and early warning

Clinical Trial Cost Analytics

End-to-end visibility into clinical trial spend — from investigator grants to CRO milestones to central lab costs. AI predicts budget variance before it materializes.

22% reduction in clinical trial cost overruns

Per-patient cost tracking by site, country, and protocol

CRO pass-through cost validation against contracts

Protocol amendment financial impact modeling

Site performance and enrollment rate-based cost forecasting

Comparator drug procurement cost optimization

Regulatory submission cost tracking by geography

Manufacturing & Quality Cost Intelligence

Profit analytics across API sourcing, formulation, fill-finish, and packaging. Quality deviation cost tracking, batch yield optimization, and GMP compliance cost visibility.

15% improvement in manufacturing gross margin

Batch cost variance analysis (API, excipients, packaging)

Quality deviation cost of non-conformance (CONC) tracking

Yield optimization analytics with ML prediction models

Contract manufacturing organization (CMO) cost benchmarking

Serialization and track-and-trace cost allocation

Environmental monitoring and clean room cost analysis

Commercial Operations Analytics

Sales force effectiveness, managed care contracting, and market access analytics that protect commercial margins and optimize resource deployment.

$12M improvement in commercial operating profit

Sales force ROI analysis by territory and therapeutic area

Managed care contract profitability modeling

Co-pay assistance program cost optimization

Market access strategy financial impact assessment

Patient hub services cost-per-patient analytics

KOL engagement ROI measurement

Customer Success

Top-20 Global Pharmaceutical Company

Challenge

Gross-to-net erosion accelerating across US portfolio with 340B exposure growing 25% year-over-year. Manual rebate reconciliation missing $8M+ in duplicate discount overpayments annually.

Solution

Deployed ProfitGuard's Drug Pricing Intelligence Engine across the US commercial portfolio, integrating SAP S/4HANA SD pricing, government rebate systems, and 340B contract pharmacy data.

Results Achieved

$23M

Annual gross-to-net improvement

99.2%

Rebate calculation accuracy

340B

Duplicate discounts eliminated

6 weeks

Implementation to first savings

Pharma Compliance Built In

FDA 21 CFR Part 11EU Annex 11GxP (GMP, GLP, GCP, GDP)DSCSA SerializationEU FMDICH GuidelinesSOX Financial ControlsGDPR Patient Data

Protect Pharma Profitability from Molecule to Market.

GxP-validated. FDA 21 CFR Part 11 compliant. See the impact on your gross-to-net in days, not months.